What is the current size of biomaterials market?

As per Precedence Research, the global biomaterials market size was valued at USD 152.58 billion in 2023 and projected to hit USD 523.75 billion by 2034. Read More

Which factors fueling the biomaterials market growth?

Rising prevalence of chronic skeletal and musculoskeletal medical conditions are predicted to propel the demand for biomaterial-based implants, thereby fuelling the market growth. Read More

How much is the CAGR of biomaterials market?

The global biomaterials market is poised to grow at a compound annual growth rate (CAGR) of 11.82% during the forecast period from 2024 to 2034. Read More

Which product segment led the global biomaterials market?

By product, polymer segment led the global biomaterials market with considerable revenue share in 2023 and projected to continue its dominance in the coming years. Read More

Why North America accounted for the maximum revenue share in the global biomaterials market?

In 2022, North America accounted for the maximum revenue share in the global biomaterials market due to significant growth in the number of surgeries in the region along with application of biomaterials in those surgeries. Read More

Which key players are operating in the biomaterials market?

Some of the key players operating in the biomaterials market are Evonik Industries AG, Medtronic plc,Berkeley Advanced Biomaterials, Corbion, Carpenter Technology Corporation, Zimmer Biomet Holdings, Inc., Invibio Ltd., Covalon Technologies Ltd., BASF SE, Johnson & Johnson, Stryker Corporation, CoorsTek Inc., DentsplySirona, and Collagen Matrix, Inc. among others. Read More

Why Asia Pacific anticipated to witness the fastest growth during the analysis period?

The Asia Pacific anticipated to witness the fastest growth during the analysis period. This is attributed to the major strategies adopted by the regional players to reinforce their presence in both global as well as regional market. Read More

Which application segment captured maximum revenue share in the global biomaterials market in 2023?

By application, the orthopedic segment captured maximum revenue share in the global biomaterials market in 2023. Rising adoption of metallic biomaterials owing to their high load bearing capacity is one of the prime factors that drive the growth of the segment. Read More

Biomaterials Market Size, Share, and Trends 2024 to 2034

The global biomaterials market size was USD 152.58 billion in 2023, estimated at USD 171.35 billion in 2024 and is anticipated to reach around USD 523.75 billion by 2034, expanding at a CAGR of 11.82% from 2024 to 2034.

Last Updated : September 2024
Report Code : 1059
Category : Chemical and Material

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Biomaterials Market, By Product

7.1. Biomaterials Market, by Product Type, 2024-2034
7.1.1. Metallic
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Ceramics
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Natural
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global Biomaterials Market, By Application

8.1. Biomaterials Market, by Application, 2024-2034
8.1.1.1. Ophthalmology
8.1.1.2. Market Revenue and Forecast (2021-2034)
8.1.1.3. Cardiovascular
8.1.1.4. Market Revenue and Forecast (2021-2034)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Wound Healing
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Orthopedic
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Plastic Surgery
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Tissue Engineering
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Neurology
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Biomaterials Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.2. Market Revenue and Forecast, by Application (2021-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

Chapter 10. Company Profiles

10.1. Evonik Industries AG
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Berkeley Advanced Biomaterials
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Corbion
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Carpenter Technology Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zimmer Biomet Holdings, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Invibio Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Covalon Technologies Ltd.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. BASF SE
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Johnson & Johnson
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Stryker Corporation
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. CoorsTek Inc.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. DentsplySirona
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

We use cookies to improve your experience

Biomaterials Market Size to Hit USD 523.75 Billion by 2034

List of Contents